Bright Minds (DRUG) outlines 2026 AGM in Vancouver with key record dates
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
Bright Minds Biosciences Inc. has filed details for its upcoming Annual General Meeting of security holders. The record date for notice, voting, and beneficial ownership determination is set for February 10, 2026, meaning holders of common shares on that date will be entitled to participate.
The Annual General Meeting is scheduled for March 31, 2026 in Vancouver. The company will use notice-and-access for both registered and beneficial holders, and it will not send proxy materials directly to NOBOs or pay for delivery to OBOs, indicating that intermediaries will handle most material distribution.
Positive
- None.
Negative
- None.
Key Figures
Record Date: February 10, 2026
Meeting Date: March 31, 2026
Meeting Location: Vancouver
+2 more
5 metrics
Record Date
February 10, 2026
Record date for notice, voting and beneficial ownership determination
Meeting Date
March 31, 2026
Annual General Meeting of security holders
Meeting Location
Vancouver
Location of the 2026 Annual General Meeting
Notice-and-Access for Beneficial Holders
Yes
NAA requirements for beneficial holders
Notice-and-Access for Registered Holders
Yes
NAA requirements for registered holders
Key Terms
Record Date for Notice of Meeting, Beneficial Ownership Determination Date, Notice and Access (NAA) Requirements, NOBO, +1 more
5 terms
Record Date for Notice of Meeting financial
"Record Date for Notice of Meeting | February 10, 2026"
Beneficial Ownership Determination Date financial
"Beneficial Ownership Determination Date | February 10, 2026"
Notice and Access (NAA) Requirements regulatory
"Notice and Access (NAA) Requirements: | NAA for Beneficial Holders | Yes"
NOBO financial
"Issuer sending proxy related materials directly to NOBO: | No"
OBO financial
"Issuer paying for delivery to OBO: | No"
FAQ
When is Bright Minds Biosciences (DRUG) 2026 Annual General Meeting?
Bright Minds Biosciences’ Annual General Meeting is scheduled for March 31, 2026 in Vancouver. This is when security holders can formally consider corporate matters and vote on items presented in the meeting materials distributed in advance.
What is the record date for Bright Minds Biosciences (DRUG) 2026 AGM?
The record date for notice and voting at Bright Minds Biosciences’ 2026 AGM is February 10, 2026. Shareholders holding common shares on that date will be entitled to receive meeting materials and exercise their voting rights at the AGM.
Where will Bright Minds Biosciences (DRUG) hold its 2026 AGM?
The 2026 Annual General Meeting of Bright Minds Biosciences will be held in Vancouver. The filing identifies Vancouver as the meeting location, with additional logistical details typically provided in the formal notice of meeting and proxy materials.
How will Bright Minds Biosciences (DRUG) deliver proxy materials for the 2026 AGM?
Bright Minds Biosciences will use notice-and-access for both beneficial and registered holders for the 2026 AGM. The issuer will not send materials directly to NOBOs or pay delivery costs for OBOs, so intermediaries will coordinate material distribution.
What is the beneficial ownership determination date for Bright Minds Biosciences (DRUG)?
The beneficial ownership determination date is February 10, 2026, the same as the record date. This date is used to determine which security holders are considered beneficial owners for voting and meeting-related purposes at the 2026 Annual General Meeting.